Mechanotransduction in Coronary Vein Graft Disease

Matthijs Steven Ruiter, Maurizio Pesce

Research output: Contribution to journalArticle

Abstract

Autologous saphenous veins are the most commonly used conduits in revascularization of the ischemic heart by coronary artery bypass graft surgery, but are subject to vein graft failure. The current mini review aims to provide an overview of the role of mechanotransduction signalling underlying vein graft failure to further our understanding of the disease progression and to improve future clinical treatment. Firstly, limitation of damage during vein harvest and engraftment can improve outcome. In addition, cell cycle inhibition, stimulation of Nur77 and external grafting could form interesting therapeutic options. Moreover, the Hippo pathway, with the YAP/TAZ complex as the main effector, is emerging as an important node controlling conversion of mechanical signals into cellular responses. This includes endothelial cell inflammation, smooth muscle cell proliferation/migration, and monocyte attachment/infiltration. The combined effects of expression levels and nuclear/cytoplasmic translocation make YAP/TAZ interesting novel targets in the prevention and treatment of vein graft disease. Pharmacological, molecular and/or mechanical conditioning of saphenous vein segments between harvest and grafting may potentiate targeted and specific treatment to improve long-term outcome.

Original languageEnglish
Pages (from-to)20
JournalFrontiers in cardiovascular medicine
Volume5
DOIs
Publication statusPublished - 2018

Fingerprint

Veins
Coronary Vessels
Transplants
Saphenous Vein
Coronary Artery Bypass
Smooth Muscle Myocytes
Cell Movement
Disease Progression
Monocytes
Cell Cycle
Endothelial Cells
Cell Proliferation
Pharmacology
Inflammation
Therapeutics

Cite this

Mechanotransduction in Coronary Vein Graft Disease. / Ruiter, Matthijs Steven; Pesce, Maurizio.

In: Frontiers in cardiovascular medicine, Vol. 5, 2018, p. 20.

Research output: Contribution to journalArticle

@article{fb478a7b97b1428c91e9850624a2fe07,
title = "Mechanotransduction in Coronary Vein Graft Disease",
abstract = "Autologous saphenous veins are the most commonly used conduits in revascularization of the ischemic heart by coronary artery bypass graft surgery, but are subject to vein graft failure. The current mini review aims to provide an overview of the role of mechanotransduction signalling underlying vein graft failure to further our understanding of the disease progression and to improve future clinical treatment. Firstly, limitation of damage during vein harvest and engraftment can improve outcome. In addition, cell cycle inhibition, stimulation of Nur77 and external grafting could form interesting therapeutic options. Moreover, the Hippo pathway, with the YAP/TAZ complex as the main effector, is emerging as an important node controlling conversion of mechanical signals into cellular responses. This includes endothelial cell inflammation, smooth muscle cell proliferation/migration, and monocyte attachment/infiltration. The combined effects of expression levels and nuclear/cytoplasmic translocation make YAP/TAZ interesting novel targets in the prevention and treatment of vein graft disease. Pharmacological, molecular and/or mechanical conditioning of saphenous vein segments between harvest and grafting may potentiate targeted and specific treatment to improve long-term outcome.",
author = "Ruiter, {Matthijs Steven} and Maurizio Pesce",
year = "2018",
doi = "10.3389/fcvm.2018.00020",
language = "English",
volume = "5",
pages = "20",
journal = "Frontiers in cardiovascular medicine",
issn = "2297-055X",

}

TY - JOUR

T1 - Mechanotransduction in Coronary Vein Graft Disease

AU - Ruiter, Matthijs Steven

AU - Pesce, Maurizio

PY - 2018

Y1 - 2018

N2 - Autologous saphenous veins are the most commonly used conduits in revascularization of the ischemic heart by coronary artery bypass graft surgery, but are subject to vein graft failure. The current mini review aims to provide an overview of the role of mechanotransduction signalling underlying vein graft failure to further our understanding of the disease progression and to improve future clinical treatment. Firstly, limitation of damage during vein harvest and engraftment can improve outcome. In addition, cell cycle inhibition, stimulation of Nur77 and external grafting could form interesting therapeutic options. Moreover, the Hippo pathway, with the YAP/TAZ complex as the main effector, is emerging as an important node controlling conversion of mechanical signals into cellular responses. This includes endothelial cell inflammation, smooth muscle cell proliferation/migration, and monocyte attachment/infiltration. The combined effects of expression levels and nuclear/cytoplasmic translocation make YAP/TAZ interesting novel targets in the prevention and treatment of vein graft disease. Pharmacological, molecular and/or mechanical conditioning of saphenous vein segments between harvest and grafting may potentiate targeted and specific treatment to improve long-term outcome.

AB - Autologous saphenous veins are the most commonly used conduits in revascularization of the ischemic heart by coronary artery bypass graft surgery, but are subject to vein graft failure. The current mini review aims to provide an overview of the role of mechanotransduction signalling underlying vein graft failure to further our understanding of the disease progression and to improve future clinical treatment. Firstly, limitation of damage during vein harvest and engraftment can improve outcome. In addition, cell cycle inhibition, stimulation of Nur77 and external grafting could form interesting therapeutic options. Moreover, the Hippo pathway, with the YAP/TAZ complex as the main effector, is emerging as an important node controlling conversion of mechanical signals into cellular responses. This includes endothelial cell inflammation, smooth muscle cell proliferation/migration, and monocyte attachment/infiltration. The combined effects of expression levels and nuclear/cytoplasmic translocation make YAP/TAZ interesting novel targets in the prevention and treatment of vein graft disease. Pharmacological, molecular and/or mechanical conditioning of saphenous vein segments between harvest and grafting may potentiate targeted and specific treatment to improve long-term outcome.

U2 - 10.3389/fcvm.2018.00020

DO - 10.3389/fcvm.2018.00020

M3 - Article

C2 - 29594150

VL - 5

SP - 20

JO - Frontiers in cardiovascular medicine

JF - Frontiers in cardiovascular medicine

SN - 2297-055X

ER -